Home » Topics » BioWorld Science

BioWorld Science
RSS

RemeGen receives Australian ethics approval for phase I trial of ADC RC-118

Aug. 2, 2021

Changes in SavaDx and plasma P-tau181 confirm treatment effect of simufilam in AD

Aug. 2, 2021

Addition of GEN-1 to standard NAC shows safety and efficacy in phase I ovarian cancer study

Aug. 2, 2021

Deuterated GC-376 variants show efficacy in model of SARS-CoV-2 infection

Aug. 2, 2021

Jiangsu Simcere Pharmaceutical R&D discovers MAT2A inhibitors

Aug. 2, 2021

Beijing Kang Dini Pharmaceutical presents new IL-8 expression inhibitors

Aug. 2, 2021

Enyo reports promising phase II data for vonafexor in patients with chronic hepatitis B

Aug. 2, 2021

DNA-dependent protein kinase inhibitors discovered at Chengdu Baiyu Pharmaceutical

Aug. 2, 2021

New glucocorticoid receptor modulators identified at Medshine Discovery

Aug. 2, 2021

FDA clears IND for phase I study of Protollin as treatment of AD

Aug. 2, 2021

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 14, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 13, 2026.
ADCs’ breakout 2025 and their still-unfinished potential
BioWorld
Over the course of the year, and continuing into the latest scientific meetings, an extraordinary breadth of new antibody-drug conjugate (ADC) designs was...
LINC01116 has prognostic value in lung cancer, study shows
BioWorld MedTech
Long noncoding RNAs (lncRNAs) have emerged as potential markers of disease, since they associate with proteins that regulate gene expression, translation or...
SERPINB1 as potential biomarker for spinocerebellar ataxia type 2
BioWorld Science
Researchers from Goethe-Universität and collaborators investigated novel molecular biomarker candidates for spinocerebellar ataxia type 2, a progressive...